The Interpretation of 2024 SMFM Consult Series: Management of Short Cervix in Individuals without A History of Spontaneous Preterm Birth

doi:10.12280/gjfckx.20250165

Abstract

Abstract:

The rate of preterm birth has been increasing in recent years, most deliveries before 34 weeks of gestation occur in individuals with no previous history of preterm birth. Since short cervix is associated with preterm birth, cervical length assessment and targeted preventive measures can reduce the incidence of preterm birth. Midtrimester cervical length assessment using transvaginal ultrasound is one of the best clinical predictors of spontaneous preterm birth. In 2024, the Society for Maternal-Fetal Medicine (SMFM) issued the Consult Series No.70: Management of short cervix in individuals without a history of spontaneous preterm birth, covering cervix length assessment, definition of short cervix and its prevention and therapy. The recommendation provides guidance for the diagnosis and management of pregnant women with short cervix without a history of preterm birth.

Key words: Cervical length measurement, Preterm birth, Therapy, Diagnostic and treatment guideline, Short cervix

LENG Qin, ZHONG Xiao-ling, YU Wei-wei. The Interpretation of 2024 SMFM Consult Series: Management of Short Cervix in Individuals without A History of Spontaneous Preterm Birth[J]. Journal of International Obstetrics and Gynecology, 2025, 52(3): 315-318.

References 34

[1]	Adams MM, Elam-Evans LD, Wilson HG, et al. Rates of and factors associated with recurrence of preterm delivery[J]. JAMA, 2000, 283(12):1591-1596. doi: 10.1001/jama.283.12.1591.
[2]	Ohuma EO, Moller AB, Bradley E, et al. National, regional, and global estimates of preterm birth in 2020, with trends from 2010: a systematic analysis[J]. Lancet, 2023, 402(10409):1261-1271. doi: 10.1016/S0140-6736(23)00878-4. pmid: 37805217
[3]	Esplin MS, Elovitz MA, Iams JD, et al. Predictive Accuracy of Serial Transvaginal Cervical Lengths and Quantitative Vaginal Fetal Fibronectin Levels for Spontaneous Preterm Birth Among Nulliparous Women[J]. JAMA, 2017, 317(10):1047-1056. doi: 10.1001/jama.2017.1373. pmid: 28291893
[4]	Society for Maternal-Fetal Medicine (SMFM). SMFM Consult Series #70: Management of short cervix in individuals without a history of spontaneous preterm birth[J]. Am J Obstet Gynecol, 2024, 231(2):B2-B13. doi: 10.1016/j.ajog.2024.05.006.
[5]	AIUM-ACR-ACOG-SMFM-SRU Practice Parameter for the Performance of Standard Diagnostic Obstetric Ultrasound Examina-tions[J]. J Ultrasound Med, 2018, 37(11):E13-E24. doi: 10.1002/jum.14831.
[6]	Friedman AM, Schwartz N, Ludmir J, et al. Can transabdominal ultrasound identify women at high risk for short cervical length?[J]. Acta Obstet Gynecol Scand, 2013, 92(6):637-641. doi: 10.1111/aogs.12111.
[7]	Prediction and Prevention of Spontaneous Preterm Birth: ACOG Practice Bulletin, Number 234[J]. Obstet Gynecol, 2021, 138(2):e65-e90. doi: 10.1097/AOG.0000000000004479.
[8]	Songserm V, Komwilaisak R, Saksiriwuttho P, et al. Transperineal versus transvaginal sonographic measurements of cervical length in pregnant women between 16 and 24 weeks of gestation[J]. J Clin Ultrasound, 2019, 47(7):389-393. doi: 10.1002/jcu.22640.
[9]	McIntosh J, Feltovich H, Berghella V, et al. The role of routine cervical length screening in selected high- and low-risk women for preterm birth prevention[J]. Am J Obstet Gynecol, 2016, 215(3):B2-B7. doi: 10.1016/j.ajog.2016.04.027.
[10]	Heath VC, Southall TR, Souka AP, et al. Cervical length at 23 weeks of gestation: prediction of spontaneous preterm delivery[J]. Ultrasound Obstet Gynecol, 1998, 12(5):312-317. doi: 10.1046/j.1469-0705.1998.12050312.x.
[11]	Vaisbuch E, Romero R, Mazaki-Tovi S, et al. The risk of impending preterm delivery in asymptomatic patients with a nonmeasurable cervical length in the second trimester[J]. Am J Obstet Gynecol, 2010, 203(5):446.e1-446.e9. doi: 10.1016/j.ajog.2010.05.040.
[12]	Leung TN, Pang MW, Leung TY, et al. Cervical length at 18-22 weeks of gestation for prediction of spontaneous preterm delivery in Hong Kong Chinese women[J]. Ultrasound Obstet Gynecol, 2005, 26(7):713-717. doi: 10.1002/uog.2617.
[13]	Guzman ER, Walters C, Ananth CV, et al. A comparison of sonographic cervical parameters in predicting spontaneous preterm birth in high-risk singleton gestations[J]. Ultrasound Obstet Gynecol, 2001, 18(3):204-210. doi: 10.1046/j.0960-7692.2001.00526.x.
[14]	Fonseca EB, Celik E, Parra M, et al. Progesterone and the risk of preterm birth among women with a short cervix[J]. N Engl J Med, 2007, 357(5):462-469. doi: 10.1056/NEJMoa067815.
[15]	Hassan SS, Romero R, Vidyadhari D, et al. Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial[J]. Ultrasound Obstet Gynecol, 2011, 38(1):18-31. doi: 10.1002/uog.9017. pmid: 21472815
[16]	Epppic Group. Evaluating Progestogens for Preventing preterm birth International Collaborative(EPPPIC): meta-analysis of individual participant data from randomised controlled trials[J]. Lancet, 2021,397:1183-1194. doi: 10.1016/s0140-6736(21)00217-8.
[17]	Romero R, Conde-Agudelo A, Da Fonseca E, et al. Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data[J]. Am J Obstet Gynecol, 2018, 218(2):161-180. doi: 10.1016/j.ajog.2017.11.576.
[18]	Rosta K, Ott J, Kelemen F, et al. Is vaginal progesterone treatment associated with the development of gestational diabetes? A retrospective case-control study[J]. Arch Gynecol Obstet, 2018, 298(6):1079-1084. doi: 10.1007/s00404-018-4895-1. pmid: 30225687
[19]	Meis PJ, Klebanoff M, Thom E, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate[J]. N Engl J Med, 2003, 348(24):2379-2385. doi: 10.1056/NEJMoa035140.
[20]	Grobman WA, Thom EA, Spong CY, et al. 17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm[J]. Am J Obstet Gynecol, 2012, 207(5):390.e1-390.e8. doi: 10.1016/j.ajog.2012.09.013.
[21]	Society for Maternal-Fetal Medicine Statement: Response to the Food and Drug Administration′s withdrawal of 17-alpha hydroxyprogesterone caproate[J]. Am J Obstet Gynecol, 2023, 229(1):B2-B6. doi: 10.1016/j.ajog.2023.04.012.
[22]	Shennan AH, Story L. Cervical Cerclage: Green-top Guideline No.75[J]. BJOG, 2022, 129(7):1178-1210. doi: 10.1111/1471-0528.17003.
[23]	To MS, Alfirevic Z, Heath VC, et al. Cervical cerclage for prevention of preterm delivery in women with short cervix: randomised controlled trial[J]. Lancet, 2004, 363(9424):1849-1853. doi: 10.1016/S0140-6736(04)16351-4. pmid: 15183621
[24]	Berghella V, Ciardulli A, Rust OA, et al. Cerclage for sonographic short cervix in singleton gestations without prior spontaneous preterm birth: systematic review and meta-analysis of randomized controlled trials using individual patient-level data[J]. Ultrasound Obstet Gynecol, 2017, 50(5):569-577. doi: 10.1002/uog.17457. pmid: 28295722
[25]	Boelig RC, Dugoff L, Roman A, et al. Predicting asymptomatic cervical dilation in pregnant patients with short mid-trimester cervical length: A secondary analysis of a randomized controlled trial[J]. Acta Obstet Gynecol Scand, 2019, 98(6):761-768. doi: 10.1111/aogs.13545.
[26]	Zafman KB, Rebarber A, Fox NS. Serial Cervical Length Evaluation in Low-Risk Women with Shortened Cervical Lengths in the Midtrimester: How Many Will Dilate Prior to 24 Weeks?[J]. Am J Perinatol, 2020, 37(1):14-18. doi: 10.1055/s-0039-1694006. pmid: 31398731
[27]	薛志伟, 刘亚娜, 王棵, 等. 宫颈托预防自发性早产的单中心前瞻性队列研究[J]. 四川大学学报(医学版), 2024, 55(4):1007-1013. doi: 10.12182/20240760501.
[28]	Saccone G, Maruotti GM, Giudicepietro A, et al. Effect of Cervical Pessary on Spontaneous Preterm Birth in Women With Singleton Pregnancies and Short Cervical Length: A Randomized Clinical Trial[J]. JAMA, 2017, 318(23):2317-2324. doi: 10.1001/jama.2017.18956. pmid: 29260226
[29]	Abdel-Aleem H, Shaaban OM, Abdel-Aleem MA, et al. Cervical pessary for preventing preterm birth in singleton pregnancies[J]. Cochrane Database Syst Rev, 2022, 12(12):CD014508. doi: 10.1002/14651858.CD014508.
[30]	Conde-Agudelo A, Romero R, Nicolaides KH. Cervical pessary to prevent preterm birth in asymptomatic high-risk women: a systematic review and meta-analysis[J]. Am J Obstet Gynecol, 2020, 223(1):42-65.e2. doi: 10.1016/j.ajog.2019.12.266. pmid: 32027880
[31]	Brizot ML, Hernandez W, Liao AW, et al. Vaginal progesterone for the prevention of preterm birth in twin gestations: a randomized placebo-controlled double-blind study[J]. Am J Obstet Gynecol, 2015, 213(1):82.e1-82.e9. doi: 10.1016/j.ajog.2015.02.021.
[32]	Norman JE, Norrie J, MacLennan G, et al. Evaluation of the Arabin cervical pessary for prevention of preterm birth in women with a twin pregnancy and short cervix (STOPPIT-2): An open-label randomised trial and updated meta-analysis[J]. PLoS Med, 2021, 18(3):e1003506. doi: 10.1371/journal.pmed.1003506.
[33]	Roman A, Zork N, Haeri S, et al. Physical examination-indicated cerclage in twin pregnancy: a randomized controlled trial[J]. Am J Obstet Gynecol, 2020, 223(6):902.e1-902.e11. doi: 10.1016/j.ajog.2020.06.047.
[34]	Brown R, Gagnon R, Delisle MF. No.373-Cervical Insufficiency and Cervical Cerclage[J]. J Obstet Gynaecol Can, 2019, 41(2):233-247. doi: 10.1016/j.jogc.2018.08.009.